ASH 2012: Dr. Kumar - Phase I/II, Multicenter, Open-Label, Dose-Escalation Study of Bendamustine in Combination with Lenalidomide and Dexamethasone (BRD) in Patients with Relapsed Multiple Myeloma: A Multiple Myeloma Research Consortium Study
Shaji Kumar, Mayo Clinic Rochester, MN
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.